Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 24.78B | 23.61B | 20.29B | 20.14B | 19.57B |
Gross Profit | 0.00 | 23.63B | 20.29B | 20.14B | 19.57B |
EBITDA | 2.75B | 3.06B | 3.50B | 3.20B | 2.97B |
Net Income | 1.82B | 1.53B | 1.88B | 1.66B | 1.52B |
Balance Sheet | |||||
Total Assets | 1.36T | 1.34T | 1.31T | 1.40T | 1.30T |
Cash, Cash Equivalents and Short-Term Investments | 0.00 | 101.97B | 86.59B | 196.34B | 103.46B |
Total Debt | 39.98B | 39.75B | 25.44B | 120.55B | 26.77B |
Total Liabilities | 1.31T | 1.29T | 1.26T | 1.35T | 1.25T |
Stockholders Equity | 55.86B | 56.83B | 54.20B | 54.75B | 51.81B |
Cash Flow | |||||
Free Cash Flow | 14.90B | -3.51B | -110.62B | 90.10B | 46.66B |
Operating Cash Flow | 15.32B | -3.02B | -110.25B | 90.73B | 47.32B |
Investing Cash Flow | -26.13B | 8.86B | 2.06B | -13.00M | -10.85B |
Financing Cash Flow | 17.39B | 17.55B | -828.00M | 2.17B | -806.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $497.43B | 11.19 | 7.63% | 3.93% | -1.55% | 45.42% | |
74 Outperform | ¥333.44B | 10.84 | 4.21% | 3.16% | 5.52% | 15.05% | |
72 Outperform | ¥25.92B | 6.72 | 3.83% | -4.52% | 85.81% | ||
70 Outperform | $771.40B | 10.57 | 7.30% | 3.48% | 15.35% | -1.62% | |
68 Neutral | ¥64.48B | 6.71 | 2.87% | 17.59% | 44.54% | ||
67 Neutral | ¥718.95B | 10.85 | 7.55% | 3.30% | 7.89% | 15.53% | |
65 Neutral | ¥14.38B | 8.77 | 4.00% | 7.92% | -20.34% |